SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending following news of a potential AI compute partnership with OpenAI, involving stock warrants and significant GPU commitments, which could drive substantial revenue growth. The community is discussing the long-term implications of this deal, including its potential impact on market share and AMD's future valuation, with some setting ambitious price targets. This development is seen as a major validation for AMD in the competitive AI chip sector.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending amid speculation of a potential partnership with Tesla, fueled by a recent video showcasing Archer's eVTOL aircraft alongside Tesla's Optimus robot. The community is actively discussing the possibility of Tesla integrating Archer's technology for autonomous air taxis and battery solutions. This buzz comes as Archer progresses towards regulatory approvals and expands into defense applications.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

Spruce Biosciences ($SPRB) is trending due to a significant surge following FDA Breakthrough Therapy designation, sparking excitement among investors. Community discussions revolve around the massive volume spike and potential for continued gains, while some warn of a potential pullback. The focus is on the company's prospects in treating Sanfilippo syndrome type B and its impact on the biotech sector.

Society Pass, Inc. engages in the operation and acquisition of fintech and e-commerce platforms and mobile applications. It operates through the following segments: Online Food and Beverage (F&B) and Groceries Deliveries, Digital Marketing, Online Ticketing and Reservation, e-Commerce, Telecommunication Reseller, and Merchant Point of Sale (POS). The Online F&B and Groceries Deliveries segment includes the operation of Handycart, Mangan, and Pushkart brands. The Digital Marketing segment involves the engagement with creators and management of platforms. The Online Ticketing and Reservation segment focuses on the sale of domestic and overseas air ticket and global hotel reservations. The e-Commerce segment refers to the operation of an online lifestyle platform under the brand name Leflair. The Telecommunication Reseller segment consists of sales of local mobile phone plans and global internet data provider plans. The Merchant POS segment covers the sale of hardware and software. The company was founded by Luan Thuc Nguyen on June 22, 2018 and is headquartered in Carson City, NV.

Society Pass Inc

SOPA is trending as traders discuss its potential as a multi-day runner, citing strong setups and breakout momentum. Community members are analyzing chart patterns, anticipating a surge, and highlighting a raised price target from Ascendiant Capital. Some caution against potential pullbacks and are wary of possible offerings.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as investors discuss the potential of deep-sea mining for critical minerals and the company's strong fundamentals. Community members are weighing the potential for government investment and comparing TMC to other companies in the sector. Some are also focused on technical analysis, noting a potential cup and handle formation.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending downwards following reports of an SEC probe into its data collection practices, sparking concerns about regulatory compliance and potential impacts on its business model. The community is debating the severity of the probe, with some viewing it as a buying opportunity amidst the uncertainty, while others fear further downside and potential removal from the S&P 500. Discussions also involve AppLovin's high valuation and comparisons to other companies in the tech and advertising sectors.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

Trending due to recent record highs and anticipation surrounding Jerome Powell's speech, $DJIA faces scrutiny regarding inflation and potential rate cuts. Community discussions revolve around economic data, potential market impacts of tariffs, and geopolitical events. Despite some bearish sentiment, many analysts remain optimistic, citing strong earnings and potential for further gains.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

GDX is trending as gold prices rally, pushing the ETF to new highs. Community discussions revolve around bullish Elliott Wave sequences, potential pullbacks as buying opportunities, and the outperformance of miners compared to gold. Some traders are noting overbought conditions and divergence, while others see further upside due to factors like dollar devaluation and geopolitical tensions.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending as investors discuss its potential for significant gains, drawing comparisons to the recent surge in IREN's valuation and the broader AI/HPC sector. Bullish sentiment is fueled by the company's Bitcoin holdings, expansion into AI data centers, and anticipation of new deals, with community members eyeing key price levels and potential short squeezes. Some are excited about the potential for a major breakout, while others remain cautious, citing past performance and the need for further developments in its AI infrastructure.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum ($QBTS) is trending amid ongoing discussions about its potential in energy-efficient AI and comparisons to other quantum computing stocks. Community members are pointing to increased institutional investment from Vanguard, while others debate the company's valuation and long-term commercial viability. There's also chatter about potential partnerships and buyout scenarios, contributing to the stock's recent upward momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cannabis Stock CRON Trades Near 52-Week High: How to Play

Cronos trades near its 52-week high as international growth boosts sales, but losses and stiff competition weigh on its outlook.

Retail sentiment picked up Sunday for Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON) and Trulieve Cannabis (TCNNF) after reports that U.S. President Donald Trump may reclassify marijuana as a less dangerous drug.&nbsp;The Wall Street Journal&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/politics/policy/trump-marijuana-federal-drug-classification-01a73b8c">said</a> that at a $1 million-a-plate fundraiser at his New Jersey golf club earlier this month, Trump told guests he was interested in the change, signaling an effort the Biden administration had started but never completed.Reclassification to Schedule III would ease restrictions, allow tax breaks, and expand medical research. Trulieve CEO Kim Rivers reportedly urged Trump to pursue the shift and expand research. Trump flagged the idea to staff. Other guests included Pfizer’s CEO, cryptocurrency executives, and political advisers.Cannabis companies have contributed millions to Trump’s political groups, hired lobbyists close to him, and backed American Rights and Reform PAC, which gave $1 million to Trump’s PAC and commissioned polling from Trump pollster Tony Fabrizio showing Republican and independent voter support.The PAC also paid $300,000 to Trump adviser Alex Bruesewitz for social media and advertising work.Bruesewitz said, “This is not calling for decriminalization or legalization but simply knocking it down a few notches on the criminal scale.”Trump said last year he would vote for legalization in Florida after meeting with Trulieve and lobbyist Brian Ballard. Senior officials said he does not personally support marijuana but is interested in “80-20 cultural issues” with broad backing and has referenced friends who used medical marijuana.Opposition groups include Smart Approaches to Marijuana, which has run ads on Fox programs, and the Community Anti-Drug Coalitions of America, which urged members to contact the White House.White House spokeswoman Abigail Jackson said, “All policy and legal requirements and implications are being considered. The only interest guiding the president’s policy decisions is what is in the best interest of the American people.”On Stocktwits, retail sentiment was “extremely bullish” with “high” message volume for ACB, CGC, and TCNNF, while CRON was “bullish” with “high” message volume.One user noted that cannabis company stocks jumped between 30% and 40% after multiple reports in April 2024 that marijuana would be reclassified to a less dangerous drug schedule.<stembedurl>https://stocktwits.com/Icarus81/message/624511957</stembedurl>Another user pointed out that the last time there was similar regulatory talk, ACB rose sharply to more than $8 a share, and said it should be “an interesting week to say the least.”<stembedurl>https://stocktwits.com/LionsFan/message/624533180</stembedurl>So far this year, ACB is up 5.4%, CGC is down 54.4%, CRON is up 13.9% and TCNNF is up 10.5%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

So far this year, ACB is up 5.4%, CGC is down 54.4%, CRON is up 13.9% and TCNNF is up 10.5%. (Photo credit: Getty Images)

Retail Bulls Pile Into Cannabis Stocks On Reports Trump May Reclassify Marijuana; Traders Eye Aurora Rally

Cannabis firms have spent millions lobbying Trump to shift marijuana to Schedule III, easing restrictions and enabling tax breaks.

Equity

New Strong Buy Stocks for July 3rd

CRON, CDE, SOUHY, PRM and STNG have been added to the Zacks Rank #1 (Strong Buy) List on July 3, 2025.

Shares of Cronos Group rose on Thursday after the cannabis company reported a first-quarter (Q1) profit and unveiled a $50 million share repurchase program.For Q1 2025, Cronos reported earnings per share (EPS) of $0.02, compared to a loss of $0.01 per share in the same period last year.&nbsp;The company’s net revenue for the quarter increased by 28% year-over-year to $32.3 million. Adjusted EBITDA stood at $2.3 million, reflecting an improvement of $13 million from the prior year’s loss of $10.7 million.Cronos Group's stock closed at $2, up 8.11% on Thursday, but dipped 0.5% to $1.99 in after-hours trading.Cronos also announced the authorization of a share repurchase program of up to $50 million, with repurchases expected to commence on May 14, and continue until May 13, 2026.The company said it may buy back up to 5% of its outstanding shares, depending on market conditions and other factors."We are confident that our Cronos GrowCo expansion, which is set for completion in Q2 2025, will provide the additional capacity necessary to meet rising demand," said Mike Gorenstein, Chairman, President, and CEO.Cronos is facing potential tariffs on its cannabis imports to Israel, with a proposed anti-dumping duty of up to 165% on Canadian medical cannabis.&nbsp;Although the duty was vetoed by Israel’s Minister of Finance, the Ministry of Economy plans to move forward.&nbsp;Cronos disagrees with the proposed tariff, arguing it would raise prices and limit patient choice in the Israeli market.&nbsp;"We continue to advocate for a fair and equitable medical cannabis market in Israel," said Gorenstein.Cronos will focus on expanding its operational capacity, with plans for the Cronos GrowCo facility expected to boost production and fuel growth in the second half of the year.On Stocktwits, Sentiment was ‘extremely bullish’ amid ‘extremely high’ message volume.Users expressed optimism, highlighting the strong earnings report and a $50 million share buyback program.&nbsp;One user noted the positive report, emphasizing its potential impact on their broader portfolio, while another congratulated the bullish sentiment, expressing satisfaction with the company's performance.<stembedurl>https://stocktwits.com/oatsuzn/message/613956979</stembedurl><stembedurl>https://stocktwits.com/A_War_Is_Coming/message/613908282</stembedurl>The stock has declined nearly 3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cronos Group Shares Rise On Strong Q1 Earnings, $50M Share Buyback: Retail Sentiment Soars

Despite facing potential tariffs on its cannabis imports to Israel, retail sentiment surged, reflecting optimism around the company’s performance and future growth prospects.

Cronos Cannabis Co. Reports 38% YOY Increase In Q3 Revenue, Boosts International Sales

Cronos' Q3 net revenue totaled $34.3 million, up by $9.5 million year-over-year. Q3 net income totaled $7.3 million compared to a net loss of $1.6 million in the prior year's period. The company has...

Canopy Growth And Other Hot Cannabis Stocks Will Soon Report Earnings, What Investors Need To Know Now

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will release its financial results for the first quarter of fiscal year 2025 ended June 30, 2024, before financial markets open on August 9...

Latest Cannabis Hires And Board Changes, Here's What You Need To Know

Long Beach, California-based vertically-integrated cannabis company Glass House Brands Inc. (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) announced last week the...

Cronos Group Sets Date for Virtual Shareholders Meeting

Cronos Group (TSE:CRON) has released an update. Cronos Group Inc. has announced the reconvening of its 2024 Annual Meeting of Shareholders to be he...

Cronos' New Cannabis Products To Help You Breeze Through Summer

Cronos Group Inc.'s (NASDAQ: CRON) (TSX: CRON) Spinach brand is expanding its portfolio of cannabis products just in time for the summer months.The Toronto-based company revealed new flavors and...

Cronos Cannabis Co. Will Provide $51M To GrowCo Toward Facility Expansion Fund

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced on Thursday an expansion of Cronos Growing Company, a cannabis cultivation business that the Toronto-based company owns 50% of.The investment...

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Cronos Group Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$2.55
Prev Close	$2.58
Open	$2.58
Dividend Yield	0.00%
50-Day Moving Average	$2.48
Beta	1.01
Avg. Volume	2.85M
PE Ratio	53.68

52-Week High	$3.16
52-Week Low	$1.60
Market Capitalization	$1.39B
EPS (Annual)	$0.1065
Price to Book	0.90
Revenue Per Employee	$256,241.83
Enterprise Value/EBITDA	N/A

CRON
Cronos Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRON News

CRON Cronos Group Inc